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Dr Peter Gloviczki (Rochester, Minn). I enjoyed your paper
very much and would like to congratulate you on an in-depth
analysis of data of mortality at 1 year. You mentioned that you
included 49 surgeons of 11 centers, and what I wanted to hear is if
your data depended on surgeon’s expertise. What has happened is
that more recently we do less open repairs in more complex
patients. We do more suprarenal or supraceliac clamping because
most of the usual bread-and-butter infrarenal aneurysms are re-
paired endovascularly. So I am wondering if surgeon’s experience
is important or not in the outcome.
When we looked recently at results of 126 juxtarenal aneu-
rysms, we found that the level of aortic clamp replacement (supra-
visceral vs suprarenal: supravisceral vs inter-renal) had no signifi-
cant effect on the development of cardiac, pulmonary, or renal
complications nor on mortality. I am wondering if you found a
difference or whether you had enough patients who had suprace-
liac clamping who maybe had a higher mortality.
Otherwise your 1-year outcome data are very similar to ours,
we had a 6% mortality by 1 year after juxtarenal aneurysm repair
and a 0.8% mortality at 30 days, which is very similar to our results
with infrarenal aortic aneurysm.
Dr Adam W. Beck. Although we have the capability of
looking at surgeon effect, we did not do so for this particular study.
I saw your publication regarding juxtarenal aneurysms. We in-
cluded all patients who had an aortic clamp above both renal
arteries, but we did not differentiate suprarenal vs supraceliac. If we
looked at just a clamp above one renal artery, those patients had a
similar outcome to the infrarenal clamp group in our database.
Dr Jack Cronenwett. When we look at these data, we find
some apparent impact of surgeon volume, but the numbers be-
come very small and impossible to accurately analyze yet in multi-
variate analysis. We are using the registry primarily for quality
improvement efforts. But overall, the 30-day mortality results in
both the open and endovascular groups were quite excellent.
Dr Tara Mastracci (Cleveland, Ohio). Thank you for your
very thoughtful analysis. This is an area of interest for us at the
Cleveland Clinic as well. I was wondering about your choice of a
1-year endpoint. In an era where we are now achieving very
acceptable perioperative outcomes for endovascular repair even in
high-risk patients who have multiple comorbidities threateninginstead of 1-year mortality, to better inform the decision to operate
on only the high-risk patients in whom we can actually prolong
survival?
Dr Beck. This is an important point. If you look at most
published risk prediction models for AAA surgery, they look pri-
marily at perioperative mortality. There are also a number of
publications that have identified independent risk factors for mor-
tality at 3 and 5 years, but no risk predictionmodels. Further, many
other factors such as subsequent cancer or heart disease affect
5-year mortality. We chose the 1-year time point because it corre-
sponds well with 1-year rupture risk, which is often discussed with
patients during decision making.
Dr JohnHallett (Charleston, SC). This is really an important
study because the methodology that you are using for vascular has
been used to improve cardiac care in your region of the country.
And, I am interested in how you are going to use this information
now with the surgeons to improve care. Are you going to use this
methodology in a prospective way so the surgeon can advise the
patient? Are you going to use it to advise the surgeon in decision-
making? How are you going to use these data in quality improve-
ment that has been used so well for cardiac surgery?
Dr Beck.We presented these data at the recent meeting of the
Vascular Study Group and it was believed to be important for
future clinical decision making. To facilitate this, it was decided to
make small pocket cards so VSGNNE members could easily re-
member these risk factors.
Dr Maciej Dryjski (Buffalo, NY). What is striking for me is
that congestive heart failure (CHF) is a predictive factor for mor-
tality in the endovascular group but not in the open group. It
seems to me that we perhaps do something different when we treat
endovascularly a patient with an aneurysm. The question is if the
dye given in perioperative evaluation, during the operation, and
then on the follow-up CTs, has an influence on 1-year postopera-
tive mortality?
Dr Beck.We did look at the amount of contrast that patients
received during EVAR in this study. We were trying to look at
preoperative data so that it could help the surgeon and the patient
make decisions before the operation. But in other analyses, we have
not found that contrast volume affected mortality after EVAR.
There were more patients in the EVAR group that had CHF
by percentile, and there were more patients that had more severe
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dent predictor of outcome in the EVAR patients and not in the
open repair patients.
Dr Jerry Goldstone (Cleveland, Ohio). One of the issues that
you did not discuss was gender differences. Were there any differ-
ences male vs female, and in particular, aneurysm size? There has
been some suggestion that women’s aneurysms may rupture at a
smaller size and, therefore, the threshold for operating might be
lower than what we.Dr Beck. We did look at gender. There was no difference in
outcomes between men and women, although your point is well
taken about aneurysm size and rupture risk. Certainly we cannot
prescribe fixed diameter thresholds for elective repair. However,
for patients with three to four identified risk factors for mortality
after open repair, it would appear that repair should be delayed
until a larger diameter is reached. On a patient-by-patient basis,
you definitely would have to consider gender in setting the optimal
diameter threshold for elective repair.
